The interaction between the tumor and host immune-specific genetic and epigenetic factors is complex and it is now clear that PD-L1 protein expression by immunohistochemistry is neither sensitive nor specific enough to serve as a reliable predictive biomarker. Here, CD274 is linked to neoplasm.